Target intelligence / Profile preview

Elongation factor 1 (EF-1)

Target
EF-1
Molecular classification
Enzyme, Translation factor, GTPase
01

Overview

Elongation factor 1 (EF-1) is a fundamental multi-protein complex in eukaryotes that mediates the enzymatic delivery of aminoacyl-tRNA to the ribosome during the elongation phase of protein synthesis (UniProt P68104). The complex consists of two main functional units: the G-protein subunit EF-1 alpha (EEF1A), which binds GTP and tRNA, and the guanine nucleotide exchange factor complex EF-1 beta/gamma/delta (EEF1B) (NCBI Gene: 1915). Beyond its primary role in translation, EF-1 is involved in non-canonical functions such as actin cytoskeleton remodeling, nuclear protein export, and the regulation of apoptosis (PMID: 25510442). In various cancers, particularly multiple myeloma and certain solid tumors, the EEF1A2 isoform is frequently overexpressed and acts as an oncogene by promoting cell survival and inhibiting pro-apoptotic pathways (PMID: 15150593). Therapeutic targeting of EF-1 has been explored with compounds like plitidepsin (Aplidin), which binds to the alpha subunit to trigger oxidative stress and JNK-mediated apoptosis in malignant cells (PMID: 32544458).

Other names
EF1EEF1Elongation factor 1 complexEukaryotic translation elongation factor 1
02

Mechanism of action

Binding to the alpha subunit (EEF1A) of the elongation factor 1 complex to inhibit protein synthesis and induce apoptosis through JNK pathway activation.

03

Biological functions

Protein synthesisTranslation elongationCytoskeletal organizationApoptosis regulationNuclear export
04

Disease associations

CancerViral infection
05

Safety considerations

MyotoxicityHematological toxicityGastrointestinal distressTransaminase elevation
06

Interacting drugs

Plitidepsin

1 more in the full profile.

07

Biomarkers

EEF1A2 expression levels

Beyond the preview

Go deeper on Elongation factor 1 (EF-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongation factor 1 (EF-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call